ABSTRACT A sensitive cell-free assay was developed for the analysis ofcorticotropin-dependent factors that stimulate the ratelimiting step of adrenal steroidogenesis. In this assay adrenal postmitochondrial supernates from corticotropin-stimulated rats caused a 10-to 100-fold increase in the de novo synthesis of pregnenolone and progesterone. A similar stimulation was observed by corresponding fractions from Leydig cells and mouse Y-1 adrenal tumor cells, but not from rat liver. Subcellular fractionation of rat adrenal tissue showed several steroidogenic factors to be present in various compartments. Recombination of them produced highly synergistic effects. The activation of some components could also be demonstrated in vitro, suggesting a cascade of events possibly linking the cAMP-dependent phosphorylation pathway with the rate-limiting step. Cycloheximide prevented the production of these steroidogenic factors in vivo upon stimulation but had no effect in vitro, suggesting a post-translational cascade involved in the activation of the cholesterol side-chain split.
Many investigations have shown that in adrenocortical or other steroidogenic tissues the appropriate tropic hormone activates the mitochondrial conversion of cholesterol to pregnenolone (1, 2) . Moreover, evidence has been presented that the actual rate-limiting step in immediate steroidogenesis is the increase in the availability of free cholesterol-i.e., its transport to the side-chain-splitting cytochrome P450 located at the matrix side of the inner mitochondrial membrane (2) (3) (4) (5) . The question still remains as to how a peptide hormone such as corticotropin (ACTH, adrenocorticotropic hormone, adrenocorticotropin) binding on a cell surface receptor can transmit a specific signal to its mitochondrial site ofaction. The current ideas on the major mechanism ofthe immediate action ofACTH on adrenocortical zona fasciculata-reticularis cells suggest the following steps: activation of adenylate cyclase in the presence of extracellular Ca2+, production of cAMP, activation of a cAMP-dependent protein kinase, and phosphorylation of specific cycloheximidesensitive proteins that may be involved somehow in activating the rate-limiting step (2, (6) (7) (8) (9) , possibly mediated by phospholipids (10) . So far, no direct link between these events has been established because of the lack of an appropriate cell-free system. Isolated adrenocortical mitochondria from ACTH-stimulated animals produce severalfold more pregnenolone than do those from unstimulated animals (2, 11, 12) , but a sensitive functional assay for extramitochondrial ACTH-dependent steroidogenic factors increasing the production ofC21 steroids in adrenal mitochondria of unstimulated animals has not been available.
Early attempts at this approach (13) failed to demonstrate a clear-cut effect. Under different conditions Ray and Strott (14) were able to demonstrate a slight increase in pregnenolone production when adrenal cytosol from ACTH-treated rats was mixed with isolated adrenal mitochondria from hypophysectomized animals. The present report describes a much more sensitive assay allowing the detection of several ACTH-dependent steroidogenic factors in various extramitochondrial fractions providing a link with the mitochondrial rate-limiting step. In addition, recombination of subcellular fractions in this assay has provided evidence for a post-translational cascade in the regulation of the cholesterol side-chain split.
MATERIALS AND METHODS Assay for extramitochondrial steroidogenic factors
Mitochondrial ACTH-Dependent Progesterone Synthesis. Pregnenolone, the first C21 conversion product of cholesterol, is easily transformed in rat adrenocortical tissue into A4-3-oxo steroids and 11,(, 18-, 19-, and 21-hydroxylated derivatives.
In order to study the neosynthesis of pregnenolone (P5) and progesterone (P4) with precision it was of paramount importance to use appropriate inhibitors of the metabolism of P5 and P4. Cyanoketone (2-cyano-4,4, 17a-trimethylandrost-5-en-17,& ol-3-one) was not suited for our purpose because it was unable to inhibit sufficiently the very active A5,3,3hydroxysteroid de- hydrogenase/5'14-isomerase present in adrenal tissue without affecting the cholesterol side-chain split. In addition the radioimmunoassay (RIA) for P5 seemed to be less specific than that for P4 because a crossreaction of P5 antiserum with lipophilic P5 esters present in adrenal tissue (15) could not be excluded. Therefore, the determination of P4 was chosen as the main measurement of the side-chain split. Mitochondrial steroidogenesis was allowed to proceed in the presence of0.27 mM Metopyrone (16) and 1.6 mM 1-(f3-guanidinoethyl)-3-(4-pyridyl)indol sulfate (Ba 40.028) (17) as inhibitors of 1l13-, 18-, and 19-hydroxylation, and 21-hydroxylation, respectively, without addition ofan electron donor. Under these conditions, after the procedure described below, tritiated P5 was recovered after Abbreviations: RIA, radioimmunoassay; P5, pregnenolone (pregn-5- The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. incubation and TLC mainly as P4 (65%) and unchanged P5 (25%) and only very little (5%) in the form of polar products.
In its simplest form the assay was performed as follows: Male rats were maintained and supplied with dexamethasone in the drinking water as described (6) (18) . All manipulations before the incubation were performed at 40C as quickly as possible; The homogenate was centrifuged at 800 x g for 10 min. The pellets containing nuclei, cell debris, and membranes (premitochondrial fractions from unstimulated or ACTH-stimulated animals) were washed once with 0.5 ml of medium A and again isolated. They were resuspended in medium A to a total volume of 0.5 ml (50 g1 per half adrenal). From the 800 X g supernates the mitochondrial fractions were obtained by centrifugation at 9000 x g for 10 min, washing of the pellets in medium A, and resuspending them in 1 ml ofmedium A-(100 pl per halfadrenal). The 9000 X g supernates containing cytosol and microsomal particles (postmitochondrial fractions) were supplemented with. medium A to a-final volume of 1 ml.
For the incubations silane-treated glass tubes (180 X 130 mm) were loaded with postmitochondrial fractions with or without premitochondrial fractions from ACTH-treated or control animals equivalent to half an adrenal and supplemented with medium A to a total volume of 250 pl. The Assay 3. In order to correct for some residual P5 in the adrenal fractions left before and after incubation, PS and P4 were determined separately in the complete incubations both at 370C and 00C. The sum of the two steroids in the latter incubation was then subtracted from the sum in the incubation at 37GC. This procedure gave the net formation of both P5 and P4 and was obviously the most accurate one. However, the results obtained by all three procedures were equivalent in terms offold increases.
For the recombination experiments postmitochondrial supernates from ACTH-treated and control animals were separated into microsomal pellets and cytosol by centrifugation at 105,000 X g for 1 hr. In the. assay aliquots of all fractions corresponded to half of an adrenal. Other methods Protein Determinations. Protein was assayed according to Lowry et aL (19) , using bovine serum albumin as standard.
Isolation of-Leydig Cell Mitochondria. Leydig cells were obtained by collagenase digestion ofadult rat testes as described (20) . For the preparation of-subcellular fractions the number of Leydig cells used was equivalent to the number of adrenocorticalscells.
Cultured Cells. The culture of the Cyc 101 mutant of the mouse adrenal-carcinoma Y-1 cell line (21) followed standard procedures. (22) . Stimulation by 3 mM cAMP was for 60 min at 370C, and fractionation ofthe cells followed the procedure given above -for isolated rat adrenocortical cells.
RESULTS

Effect of Extramitochondrial Fractions on Adrenal
Mitochondrial P4 Synthesis. Fig. 1 shows the net increase in mitochondrial P4-formation when the postmitochondrial supernate of adrenocortical tissue from control animals (PMTS) was gradually replaced by-the corresponding supernate from animals stimulated by ACTH in vivo (PMTSA). In further experiments using the various assays (see Materials and Methods and Table 1 ) PMTSA was able to increase net P4 synthesis in mitochondria from untreated rats 10-to 100-fold in comparison to PMTS. The P4.1evel reached compared favorably with that obtained by using PMTSA and mitochondria from ACTH-treated rats. Even when the mitochondria from ACTH-treated rats were used, a small increase in formation by PMTSA increased markedly; however, the net increase due to PMTSA was maintained and not abolished by the presence of reducing equivalents. The assay was not affected by the presence of 1 mM EGTA sequestering Ca2". Exogenous cholesterol up to a concentration of 200 ng per half adrenal equivalent of control mitochondria was not converted to more than 0.1% to P5 and P4 under the conditions of the assay. Nor did the addition of cholesterol interfere with the effect of PMTSA. The steroidogenic activity in PMTSA was very temperature sensitive and was stable at 40C for not more than a few hours. Heat treatment-e. g., 10 min at 90'C abolished the activity. Specificity and Crossreactivity of Steroidogenic Factors. The specificity of stimulation by postmitochondrial factors was tested by using subcellular fractions of rat liver and mouse adrenal carcinoma tumor cells (Y-1 Cyc 101). The postmitochondrial supernate ofliver from ACTH-stimulated animals was unable to stimulate the de novo synthesis of P5 and P4 in adrenal mitochondria from unstimulated rats ( Table 2 , first column). In contrast, postmitochondrial supernates from cAMP-stimulated cultured adrenal carcinoma cells were able to increase the P5 and P4 production 9-to 10-fold.
The specificity and crossreactivity of different unstimulated mitochondrial fractions was studied with steroid-elaborating Effect of Cycloheximide. The inhibitory effect of cycloheximide in intact adrenocortical cells on protein synthesis and ACTH-induced steroidogenesis led to the hypothesis ofthe involvement of a labile protein (24) . It appeared that the cycloheximide-sensitive factor acts at the level of the rate-limiting step (2, 3, 12) . When cycloheximide was administered in vivo 10 min before ACTH, the steroidogenic capacity ofthe resulting postmitochondrial supernate during incubation with control mitochondria was completely lost. However, when cycloheximide (10 ,uM) was added in vitro to the cell-free assay system no inhibition of the steroidogenic activity of PMTSA was observed.
Subcellular Distribution and Recombination of ACTH-Dependent Steroidogenic Factors. Subcellular fractions from adrenals of unstimulated and ACTH-stimulated rats were prepared separately [the nuclear 800 x g pellets (NP, NPA), the microsomal 105,000 X g pellets (MP, MPA), and the 105,000 x g cytosol fractions (CS, CSA)] and incubated singly or in combinations with control mitochondria. Results are shown in Table  3 . It is evident that the P4 synthesis increased with increasing participation of fractions from stimulated animals (A fractions) and that the 20-fold stimulation of CSA + MPA (6880 pg) over CS + MP (300 pg) corresponded to the usual effect of the postmitochondrial fraction from stimulated animals over the postmitochondrial fraction from control animals. In addition, it can be seen that NPA contributed about as much as MPA in combination with both CSA and CS.
However, there were a few important exceptions to be found that are of particular interest (see Table 3 ).
(i) Highly synergistic effects (4-to 6-fold) are produced by combinations MPA + NPA, MPA + NPA + CS or CSA, MP + NP + CSA, MPA + NP + CSA, and MP + NPA + CSA.
This means that different steroidogenic factors may be present in the fractions and cooperate for maximal steroidogenesis. (ii) One ofthe most surprising synergistic effects was the combination of MP + NP + CSA, which produced 11,070 pg of P4 and which equaled the capacity ofthe combination MPA + NPA (10,440 pg) . This suggested that CSA was able to transform MP + NP into MPA + NPA-like material at least partly under assay conditions.
(iii) It is also noteworthy that CS, although having the least efficacy by itself, was able to further increase the already high steroidogenic effect of MPA + NPA (10, When MPA + NPA formed in vivo were preincubatedwith CS in vitro in the absence of mitochondria and the cytosolic fraction was reisolated and incubatedwith control mitochondria, the steroidogenic capacity of the resulting supernate increased-about 100 times (Table 4) . DISCUSSION A sensitive cell-free assay for the detection ofACTH-dependent steroidogenic factors was designed; adrenal mitochondria from dexamethasone-blocked rats and selective inhibitors ofprogesterone metabolism were used. In this assay postmitochondrial adrenal supernates from ACTH-stimulated rats increased the cholesterol side-chain split 10-to 100-fold by comparison with equivalent supernates from dexamethasone-blocked rats (Fig.  1, Table 1 ). This increase was nearly as high as that obtained with mitochondria from stimulated animals (Table 1) , suggesting that the steroidogenic capacity of mitochondria stimulated in vivo could be generated in control mitochondria in vitro by postmitochondrial supernates of stimulated animals. The capacity of these fractions to increase mitochondrial side-chain split was not abolished by an increased supply of electron donors, NADPH, or free cholesterol.
In this functional assay subcellular fractions from steroidelaborating tissue, such as rat adrenals, rat Leydig cells, or a cultured mouse adrenal carcinoma cell line, could be interchanged; fractions from liver were inert. Whereas the administration of cycloheximide in vivo before ACTH treatment prevented the increased side-chain split in the assay, the steroidogenic effect of the postmitochondrial supernate of ACTH-stimulated rats was not abolished in vitro by cycloheximide.
The studies with subcellular fractions have clearly demonstrated the presence ofseveral ACTH-dependent steroidogenic factors in various compartments of the adrenal cortex. Recombination experiments shown in Tables 3 and 4 suggest the participation of a post-translational cascade in the regulation of the mitochondrial rate-limiting step (2-5) producing P5 and P4. Thus, a factor A, generated by ACTH in vivo, in the cytosol (CSA), may subsequently activate components B and C in the 800 X g and 105,000 X g pellets (NP + MP). One of them may transform a substrate in the cytosol (CS) to D, which may be involved in the relief of the rate-limiting constraint of steroidogenesis at the matrix side ofthe inner mitochondrial membrane. The possibility ofa different distribution ofthese factors in intact cells cannot be ruled out. Nevertheless the operation of a cascade seems very likely. It has been shown that in intact adrenocortical cells steroidogenic concentrations of ACTH were accompanied by a cAMP-dependent phosphorylation of at least one cytosolic protein (8) . The present results indicate that one of the factors participating in the cascade mentioned above could be the post-translational link in the immediate stimulation ofsteroidogenesis after the ACTH-and cAMP-dependent phosphorylation pathway. Further studies are necessary in order to pinpoint candidates for this link, such as cholesterol transporters, specific phospholipids (10), or factors involved in phospholipid metabolism (25) . It is well known that phospholipids affect the activity ofmembrane-bound enzymes such as the side-chain splitting cytochrome P-450 (26, 27) .
The detection of several compartmentalized ACTH-dependent factors in the adrenal cortex, the finding of highly synergistic effects between them, and the possibility ofassaying their interaction in a cell-free system open widely the study oflinked events in steroidogenesis. Our 
